William Zellmer talks with Kevin Garey and Pablo Okhuysen about strategies for prevention and treatment of recurrent Clostridioides difficile infection.

William Zellmer talks with Christine Walko and Shetal Patel about immune checkpoint inhibitors.

In Part 3 of this three-part interview on revised USP Chapter , William Zellmer talks with Patricia Kienle, Ashley Duty, and Eric Kastango about practical approaches for attaining compliance.

In Part 2 of this three-part interview on revised USP Chapter , William Zellmer talks with Patricia Kienle, Ashley Duty, and Eric Kastango about changes that may be needed to get your facility ready.

In Part 1 of this three-part interview on revised USP Chapter , William Zellmer talks with Patricia Kienle, Ashley Duty, and Eric Kastango about key changes to note.

William Zellmer talks with John Petrich and Michael Storey about gene therapies and considerations for integrating them into pharmacy practice.

Angela Cassano talks with Ryan Forrey about insourcing compounded sterile products and how he addressed the challenges faced at Emory University Hospital Midtown.

Part 2: Future Treatment Options and Roles for Pharmacists in Individualizing Insulin Therapy In Part 2 of this two-part “Engaging the Experts” interview, William Zellmer talks with Curtis L. Triplitt, Susan Cornell, and Joshua J. Neumiller regarding future treatment options for type 2 diabetes and the roles for pharmacists in individualizing insulin therapy. This installment is produced by A S H P Advantage and supported by Novo Nordisk Inc. Faculty: Curtis Triplitt, PharmD, CDE Associate Director, Diabetes Research Center, Texas Diabetes Institute Associate Professor, Department of Medicine, Division of Diabetes University of Texas Health Science Center at San Antonio San Antonio, Texas Susan Cornell, PharmD, CDE, FAPhA, FAADE Associate Director of Experiential Education Associate Professor, Department of Pharmacy Practice Midwestern University Chicago College of Pharmacy Downers Grove, Illinois Joshua Neumiller, PharmD, CDE, FASCP Vice Chair and Associate Professor, Department of Pharmacotherapy Washington State University College of Pharmacy Spokane, Washington C.E. Credits: This activity is not eligible for continuing education credits.

Part 1: Barriers to Optimizing the Use of Insulin in Managing Type 2 Diabetes In Part 1 of this two-part “Engaging the Experts” interview, William Zellmer talks with Curtis L. Triplitt, Susan Cornell, and Joshua J. Neumiller regarding the barriers to optimizing the use of insulin in managing patients with type 2 diabetes. This installment is produced by ASHP Advantage and supported by Novo Nordisk Inc. Faculty: Curtis Triplitt, PharmD, CDE Associate Director, Diabetes Research Center, Texas Diabetes Institute Associate Professor, Department of Medicine, Division of Diabetes University of Texas Health Science Center at San Antonio San Antonio, Texas Susan Cornell, PharmD, CDE, FAPhA, FAADE Associate Director of Experiential Education Associate Professor, Department of Pharmacy Practice Midwestern University Chicago College of Pharmacy Downers Grove, Illinois Joshua Neumiller, PharmD, CDE, FASCP Vice Chair and Associate Professor, Department of Pharmacotherapy Washington State University College of Pharmacy Spokane, Washington C.E. Credits: This activity is not eligible for continuing education credits.

In Part 1 of this two-part “Engaging the Experts” interview, William Zellmer talks with Edward Li and James Stevenson regarding the status of biosimilars in the European Union and United States. Faculty: Edward C. Li, Pharm.D., M.P.H., BCOP, Activity Chair Associate Professor Department of Pharmacy Practice University of New England College of Pharmacy Portland, Maine James G. Stevenson, Pharm.D., FASHP Professor, Department of Clinical Pharmacy University of Michigan College of Pharmacy President, Hospital and Health System Services Visante, Inc. Ann Arbor, Michigan C.E. Credits: This activity is not eligible for continuing education credits.